Cargando…
Cost-effectiveness Analysis of Genetic Testing and Tailored First-Line Therapy for Patients With Metastatic Gastrointestinal Stromal Tumors
IMPORTANCE: Gastrointestinal stromal tumor (GIST) is frequently driven by oncogenic KIT variations. Imatinib targeting of KIT marked a new era in GIST treatment and ushered in precision oncological treatment for all solid malignant neoplasms. However, studies on the molecular biological traits of GI...
Autores principales: | Banerjee, Sudeep, Kumar, Abhishek, Lopez, Nicole, Zhao, Beiqun, Tang, Chih-Min, Yebra, Mayra, Yoon, Hyunho, Murphy, James D., Sicklick, Jason K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522695/ https://www.ncbi.nlm.nih.gov/pubmed/32986105 http://dx.doi.org/10.1001/jamanetworkopen.2020.13565 |
Ejemplares similares
-
TGF-β1-mediated transition of resident fibroblasts to cancer-associated fibroblasts promotes cancer metastasis in gastrointestinal stromal tumor
por: Yoon, Hyunho, et al.
Publicado: (2021) -
Cancer-associated fibroblast secretion of PDGFC promotes gastrointestinal stromal tumor growth and metastasis
por: Yoon, Hyunho, et al.
Publicado: (2021) -
Optimizing Surgical and Imatinib Therapy for the Treatment of Gastrointestinal Stromal Tumors
por: Sicklick, Jason K., et al.
Publicado: (2013) -
Loss of the PTCH1 tumor suppressor defines a new subset of plexiform fibromyxoma
por: Banerjee, Sudeep, et al.
Publicado: (2019) -
Laparoscopic Gastric Tailoring for Huge Subcardial Gastrointestinal Stromal Tumor
por: Bogoevski, D., et al.
Publicado: (2007)